Cancer Network Podcasts
MBCC: HER2-Positive Breast Cancer Demonstrates Heterogenous Outcomes
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:03:33
- Mas informaciones
Informações:
Sinopsis
The discovery of human epidermal growth factor receptor 2 (HER2)-positive breast cancer subtypes is not yet complete, according to Mark D. Pegram, MD, who will be delivering a presentation on the different clinical outcomes of these subtypes at the Miami Breast Cancer Conference this week.
